Search clinical trials for: CTL019
Total 37 results
-
University of PennsylvaniaNot yet recruiting
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic LeukemiaBelgium, Germany, France, Austria, Canada, Italy, Japan, Norway, Spain
-
Novartis PharmaceuticalsWithdrawnB-cell Acute Lymphoblastic Leukemia
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnB-cell Acute Lymphoblastic Leukemia | Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic Leukemia
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
Novartis PharmaceuticalsCompletedB-cell Acute Lymphoblastic Leukemia | Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic LeukemiaUnited States
-
University of CologneNovartisTerminated
-
Novartis PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic LeukemiaJapan, Canada
-
Novartis PharmaceuticalsActive, not recruitingFollicular LymphomaUnited States, Spain, Belgium, Japan, Australia, Germany, Italy, Netherlands, Norway, United Kingdom, Austria, France
-
Novartis PharmaceuticalsChildren's Oncology GroupRecruitingB-Cell Acute Lymphoblastic LeukemiaUnited States, Belgium, Italy, Canada, Sweden, Netherlands, Norway, United Kingdom, Germany, Spain, France, Finland, Denmark
-
Novartis PharmaceuticalsCompletedB-cell Acute Lymphoblastic LeukemiaUnited States, Belgium, Germany, Austria, Canada, Italy, Japan, Norway, Australia, France, Spain
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaAustria, Canada, United States
-
Novartis PharmaceuticalsAvailableAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-cell Lymphoma (DLBCL)United States, Canada, Australia
-
Zhejiang UniversityShanghai Zeke Biotechnology Co.，LtdTerminated
-
University of PennsylvaniaCompletedAcute Lymphocytic Leukemia | Diffuse Large Cell LymphomaUnited States
-
OPKO Health, Inc.Completed
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
University of PennsylvaniaChildren's Hospital of PhiladelphiaActive, not recruitingAcute Lymphoid LeukemiaUnited States
-
Taiwan Liposome CompanyCompleted
-
ExelixisTerminated
-
ExelixisTerminatedMyeloproliferative Disorders | Polycythemia Vera | Thrombocythemia, Essential | MyelofibrosisUnited States
-
Miltenyi Biomedicine GmbHICON plcActive, not recruitingB-cell Non Hodgkin LymphomaGermany
-
Novartis PharmaceuticalsWithdrawn
-
Second Affiliated Hospital, School of Medicine,...CompletedTransformed Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | Primary Mediastinal Large B-cell LymphomaChina
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyCanada, United States
-
Cessatech A/SCompleted
-
Cessatech A/SNot yet recruiting
-
University of AberdeenNHS GrampianCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedDLBCLBulgaria, Estonia, France, Hungary, Italy, Latvia, Poland, Russian Federation, Spain, Ukraine
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
Teva Pharmaceutical Industries, Ltd.CompletedRheumatoid ArthritisCzechia, Hungary, Italy, Spain, United Kingdom
-
Cessatech A/SCompleted
-
Cessatech A/SSmerud Medical Research International AS; Dantrials ApsCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma (FL)Australia, Korea, Republic of, Spain, Singapore, Poland, Taiwan, Hungary, Romania, Slovakia